Showing results (1-10 of 581) with videos related to

Sort By:
Pageof 59
Cancer Biology & Therapy|September 8, 2012
Loss of OATP1B3 function causes Rotor syndrome: implications for potential use of inhibitors in cancerElias Pratt, Tristan M Sissung, William D Figg
Cancer Biology & Therapy|October 20, 2009
A genomic strategy for predicting androgen receptor activity in prostate tumorsJohann G Jonsson, Tristan M Sissung, William D Figg
Cancer Biology & Therapy|January 29, 2011
CHIP and gp78-mediated ubiquitination of CYP3A4: Implications for the pharmacology of anticancer agentsCody J Peer, Tristan M Sissung, William D Figg
Cancer Biology & Therapy|January 21, 2010
Stromal-epithelial interactions are responsible for prostate tumor progression through an androgen-related mechanismHaveesh Sharma, Tristan M Sissung, Heather Pressler, et al.
BJU International|January 14, 2010
More than an accessory: implications of type III transforming growth factor-beta receptor loss in prostate cancerSeun Ajiboye, Tristan M Sissung, Nima Sharifi, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
Pharmacogenetics of membrane transporters: a review of current approachesTristan M Sissung, Erin R Gardner, Rui Gao, et al.
Anti-Cancer Agents in Medicinal Chemistry|September 2, 2009
Current status of thalidomide and CC-5013 in the treatment of metastatic prostate cancerTristan M Sissung, Silja Thordardottir, Erin R Gardner, et al.
Pageof 59